Testimonials
GOOD Day!!
Just to tell you the package arrived TODAY !!!
i RECEVED THE MISSING PACKAGE TODAY AND THE THE ADDED GIFT. (--> Thanks!)
i WANT TO THANK YOU VERY MUCH FOR YOUR EXCELLENT FOLLOW UP AND CUSTOMER SERVICE!
You are a very impressive company and I will surely pass the higest recommendation to my associates and friends.
Thanks again for your fast solutioin, As I am also in customer serivce, I really appreciate the care you have given , and promise to do the same to my customers.
- Mark
Call us toll free:
News
- UCL spinout takes nano-enabled pain therapy to international markets - MTBeurope
UCL spinout takes nano-enabled pain therapy to international marketsMTBeuropeThe UK Nanotechnology Knowledge Transfer Network (NanoKTN) has announced that member company Nanomerics, a spin-out from UCL School of Pharmacy, is taking its patented nano-enabled therapeutic technology to international markets.
- Skepticism grows around Medco/Express Scripts deal - Reuters
WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .
- Applied DNA Sciences installs first pharmacy security system - Securing Pharma
Applied DNA Sciences installs first pharmacy security systemSecuring PharmaApplied DNA Sciences has installed its smartDNA anti-intruder mist system at a pharmacy in Long Island, USA, in response to a spate of pharmacy robberies there in recent months.
- Memo offers new account of ATF agent's NY shooting - USA TODAY
USA TODAYMemo offers new account of ATF agent's NY shootingUSA TODAYGARDEN CITY, NJ (AP) – A document accidentally posted on a prosecutor's website cites a pharmacist's version of the friendly fire shooting death of a federal agent during a New Year's Eve robbery and differs from an account offered by an attorney for .
- FDA approves first Cushing's syndrome drug, Corcept's Korlym - The Pharma Letter
FDA approves first Cushing's syndrome drug, Corcept's KorlymThe Pharma LetterShares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.
![]() |
Bookmark this site |
|---|
![]() |
Subscribe to the News |
|---|
![]() | Sitemap |
|---|







.





